PTK2 and pancreatic neoplasm: Furthermore, KLK10 enhances epithelial–mesenchymal transition (EMT) and activates FAK-SRC-ERK signaling, thereby promoting invasion and metastasis in pancreatic cancer, further implicating KLK10 in PDAC initiation and progression [17].